Project: Extracellular proteases and the cancer degradome: Innovative diagnostic markers, therapeutic targets and tumour imaging agents
- project duration
- 01-JAN-04 – 30-JUN-05
- In this 4 year Integrated Project the EUCPC aims to: 1) Define new molecular targets for drug design. 2) Develop novel specific interventions that are based on thorough knowledge of the pathophysiological roles of target proteases and related molecules, and understand how and when to use them. 3) Identify new molecular diagnostic and prognostic indicators .4) Provide new ways to enhance visualization of tumours in the clinic.